BioOxi

Biotech company Willow Biosciences Inc. (TSX:WLLW) (OTCQB:CANSF) generated nearly $1.3 million in revenues in 2023, increasing approximately 60% over the period. Dr. Chris Savile, president and CEO of the company called 2023 a "transformative year for Willow," which relies on synthetic biology...